Vernal Biosciences Announces Strategic Leadership Appointments to Drive Growth in mRNA and LNP Formulation
Interested in the cutting-edge advancements happening at Vernal Biosciences? Take a look at our featured article on BusinessWire and discover the incredible capabilities our new Chief Commercial…
Vernal Biosciences Showcases Cutting-Edge Innovations at the 11th International mRNA Health Conference in Berlin
Experience the incredible insights Vernal has to offer regarding its cutting-edge capping technology and the exceptional quality of our mRNA. We will be showcasing this groundbreaking information…
Vernal Biosciences Announces Partnership with REPROCELL
Vernal is excited to announce its new partnership with REPROCELL, furthering our mission to democratize access to mRNA, a life-changing technology, around the world. REPROCELL is a trusted leader…
Vernal featured on Businesswire
Find our latest article on Businesswire here: Vermont-based CDMO, Vernal Biosciences Announces an Additional $20MM in Funding to Expand GMP mRNA and LNP Manufacturing Click the orange…
Vermont Celebrates Vernal Success in a VT Digger Article
Every success has an origin story. Check out this new VT Digger article on how CEO Christian Cobaugh, Ph.D. founded Vernal Biosciences, and what makes Vernal uniquely…
Vernal Biosciences featured in Endpoints News regarding latest funding!
After a successful extension of its Series A funding, Vernal Biosciences was featured in an Endpoints News article by Tyler Patchen. Find out how we are using…